Insmed to present at september investor conferences

Bridgewater, n.j. , aug. 21, 2025 /prnewswire/ -- insmed incorporated (nasdaq: insm), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences: wells fargo 2025 healthcare conference in boston, on friday, september 5, 2025, at 8:00 a.m.
INSM Ratings Summary
INSM Quant Ranking